ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality-dependent prognostic patterns

Luo, Shangyi*; Zhang, Yajing; Jia, Ying; Zhang, Xue*哈尔滨医科大学; 中国医学科学院
Neuropathology and Applied Neurobiology2022-10DOI: 10.1111/nan.12831
1被引4阅读
引用收藏
分享

摘要

Aims Intratumoural heterogeneity (ITH) has been implicated in tumour growth and progression as well as therapy resistance. However, the extent of ITH of somatic copy number alterations (ITH-SCNAs) as a result of tumour evolution and its influence on clinical outcomes in diffuse glioma (DG) remain poorly understood. Methods We used an integrated computational method to infer clonal and subclonal SCNAs in 760 untreated primary DGs from The Cancer Genome Atlas. ITH-SCNAs at the genome-wide, peak (region with recurrent SCNAs) and gene level were calculated. We used the Kaplan-Meier estimators and Cox proportional hazards models to examine the associations of ITH-SCNA with patient outcomes. An independent cohort of 243 patients with paired initial and recurrent tumours from the Glioma Longitudinal Analysis Consortium was used for validation. Results DGs showed widespread ITH-SCNA, with a median of 25.5% of SCNAs identified as subclonal. We found that clonal SCNA burden had stronger prognostic power than total SCNAs in IDH-mutant astrocytoma. Coamplifications of receptor tyrosine kinases (RTKs) tended to be subclonal, and subclonal RTK amplification was significantly associated with high tumour proliferative potential and unfavourable clinical outcomes in IDH-wild-type glioblastoma. In addition, we found that the prognostic values of the peak-level SCNAs were related to their mutated clonal architecture, from which three clonality-dependent prognostic patterns of SCNAs were proposed, including clonal-dominant, subclonal-dominant and clonality-independent schemas. Conclusions The systematic analysis of ITH-SCNAs in large cohorts of DGs highlighted the importance of considering the clonality of SCNA in discovery of tumour prognostic markers.

学科与关键词

关键词
diffuse gliomaintratumoural SCNA heterogeneityprognosisreceptor tyrosine kinasetumour clonalsubclonal SCNA burden
相关
加载中…
  • Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma
    Bai, Ming; Wang, Xiaolong; Zhang, Huixue; Wang, Jianjian; Lyaysan, Gaysina; Xu, Si; Tian, Kuo; Wang, Tianfeng; Li, Jie; Wang, Na; Lu, Xiaoyu*; Zhang, Xiaoming*; Wang, Lihua*Biomed Research International, 2022, 2022.被引 2
  • Whole exome sequencing reveals the genetic heterogeneity and evolutionary history of primary gliomas and matched recurrences
    Xu, Peng-Fei; Li, Cong; Xi, Shao-Yan; Chen, Fu-Rong; Wang, Jing; Zhang, Zhi-Qiang; Liu, Yan; Li, Xin*; Chen, Zhong-Ping*Computational and Structural Biotechnology Journal, 2022, 20: 2235-2246.被引 8
  • Systematic investigation of the prognostic impact of clonal status of somatic mutations across multiple cancer types
    Cheng, Peng; Lan, Yujia; Liao, Jianlong; Zhao, Erjie; Yan, Haoteng; Xu, Liwen; Suru, A.; Ping, Yanyan*; Xu, Jinyuan*Genomics, 2022, 114(4): 110412.
查看全部 →

发表信息

论文状态
公开发表
期刊
Neuropathology and Applied Neurobiology
发表日期
2022-10
卷期
第 48 卷, 第 6 期
页码
e12831
DOI
10.1111/nan.12831
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2021MD703831, 2020M681111]; Heilongjiang Postdoctoral Funds for Scientific Research [LBH-Z20168, LBH-Z20170]; Heilongjiang Postdoctoral Young Talents Program [LBH-TZ2114]; National Natural Science Foundation of China [62102122]; Tou-Yan Innovation Team Program of the Heilongjiang Province [2019-15]; Basic Scientific Research Funds of Heilongjiang Provincial Universities

作者

  • L

    Luo, Shangyi (通讯) (第一作者)

    harbin med univ · cams

  • Z

    Zhang, Yajing

    harbin med univ · cams

查看全部 4 位作者收起作者
  • J

    Jia, Ying

    harbin med univ

  • Z

    Zhang, Xue (通讯)

    harbin med univ · cams

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417